{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:36:24Z","timestamp":1790339784471,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017515","name":"Heidelberger Stiftung Chirurgie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jss.2020.03.067","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:50:05Z","timestamp":1588855805000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model"],"prefix":"10.1016","volume":"253","author":[{"given":"Lukas F.","family":"Liesenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-3250","authenticated-orcid":false,"given":"H. Christian","family":"Hillebrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.03.067_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2020.03.067_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2020.03.067_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(17)30336-4","article-title":"Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer","volume":"18","author":"Tseng","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-3-26","article-title":"Follow-up of patients with curatively resected colorectal cancer: a practice guideline","volume":"3","author":"Figueredo","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2020.03.067_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ejso.2005.06.002","article-title":"Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study","volume":"31","author":"Bloemendaal","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib10","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib11","doi-asserted-by":"crossref","first-page":"LBA3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","article-title":"A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7","volume":"36","author":"Quenet","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2020.03.067_bib13","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","article-title":"Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States","volume":"21","author":"Turaga","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib14","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","article-title":"A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin","volume":"16","author":"Cao","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4251\/wjgo.v2.i2.109","article-title":"A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy","volume":"2","author":"Yan","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/codi.13593","article-title":"Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines","volume":"19","author":"Klaver","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jss.2020.03.067_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/jcm7120567","article-title":"Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer","volume":"7","author":"Yurttas","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jss.2020.03.067_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","article-title":"Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution","volume":"13","author":"Elias","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00280-005-0074-8","article-title":"Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C","volume":"57","author":"Sugarbaker","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2020.03.067_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jss.2020.03.067_bib21","first-page":"88","article-title":"Therapeutic efficacy of alpha-RIT using a (213)bi-anti-hCD138 antibody in a mouse model of ovarian peritoneal carcinomatosis","volume":"2","author":"Derrien","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jss.2020.03.067_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jss.2008.05.002","article-title":"Body surface area prediction in normal, hypermuscular, and obese mice","volume":"153","author":"Cheung","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2020.03.067_bib23","first-page":"5758","article-title":"Heat-induced protection of mice against thermal death","volume":"43","author":"Li","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2020.03.067_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib25","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/cncr.25116","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jso.23464","article-title":"Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models","volume":"109","author":"Gremonprez","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s002800000214","article-title":"Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy","volume":"47","author":"Pestieau","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2020.03.067_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jviscsurg.2017.10.008","article-title":"A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin","volume":"155","author":"Miailhe","year":"2017","journal-title":"J Visc Surg"},{"key":"10.1016\/j.jss.2020.03.067_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002800050721","article-title":"Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model","volume":"41","author":"Jacquet","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2020.03.067_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1096-9098(200102)76:2<106::AID-JSO1020>3.0.CO;2-E","article-title":"Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies","volume":"76","author":"Pestieau","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00280-004-0779-0","article-title":"Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model","volume":"54","author":"Glehen","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2020.03.067_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jso.20161","article-title":"Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study","volume":"89","author":"Makrin","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib33","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1158\/0008-5472.CAN-06-4353","article-title":"Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2020.03.067_bib34","series-title":"Peritoneal Carcinomatosis: Principles of Management","first-page":"53","article-title":"Peritoneal-plasma barrier","author":"Jacquet","year":"1996"},{"key":"10.1016\/j.jss.2020.03.067_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000011847","article-title":"Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies","volume":"55","author":"Jacquet","year":"1998","journal-title":"Oncology"},{"key":"10.1016\/j.jss.2020.03.067_bib36","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jss.2020.03.067_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrclinonc.2009.217","article-title":"Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence","volume":"7","author":"Ceelen","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib38","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00685503","article-title":"Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy","volume":"28","author":"Los","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jss.2020.03.067_bib40","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/1097-0142(19921215)70:12<2754::AID-CNCR2820701205>3.0.CO;2-A","article-title":"Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis","volume":"70","author":"Fujimoto","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000227211","article-title":"Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues","volume":"50","author":"Panteix","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.jss.2020.03.067_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(97)00370-5","article-title":"Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines","volume":"34","author":"van de Vaart","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.03.067_bib43","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdh398","article-title":"Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance","volume":"15","author":"Elias","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4251\/wjgo.v2.i1.19","article-title":"Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer","volume":"2","author":"Sugarbaker","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib45","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.03.067_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420302018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420302018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:50:41Z","timestamp":1758379841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420302018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":47,"alternative-id":["S0022480420302018"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.03.067","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.03.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}